SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-062183
Filing Date
2009-11-03
Accepted
2009-11-03 16:22:49
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09-31017_110q.htm 10-Q 726441
2 EX-10.1 a09-31017_1ex10d1.htm EX-10.1 535733
3 EX-10.2 a09-31017_1ex10d2.htm EX-10.2 143424
4 EX-10.3 a09-31017_1ex10d3.htm EX-10.3 303127
5 EX-31.1 a09-31017_1ex31d1.htm EX-31.1 9224
6 EX-31.2 a09-31017_1ex31d2.htm EX-31.2 8940
7 EX-32 a09-31017_1ex32.htm EX-32 7212
  Complete submission text file 0001104659-09-062183.txt   1735516
Mailing Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121
Business Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 8589090736
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33291 | Film No.: 091154753
SIC: 2834 Pharmaceutical Preparations